Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
Alessandro Prete, Antonio Matrone, Carla Gambale, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3200-3200
Open Access | Times Cited: 23

Showing 23 citing articles:

Anaplastic Thyroid Carcinoma: An Update
Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 89
Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives
Ruolei Wang, Chunyan Wang, Lianheng Lu, et al.
Pharmacological Research (2023) Vol. 199, pp. 107032-107032
Open Access | Times Cited: 36
Comprehensive Treatment of Anaplastic Thyroid Cancer: A Case Report
Jiaqi Liu, Jun Chu
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 325-333
Open Access | Times Cited: 1
Genetic Changes in Thyroid Cancers and the Importance of Their Preoperative Detection in Relation to the General Treatment and Determination of the Extent of Surgical Intervention—A Review
Jiří Hložek, Barbora Pekova, Jan Rotnágl, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1515-1515
Open Access | Times Cited: 25
Molecular features of aggressive thyroid cancer
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
Qi Liu, Wei Sun, Hao Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells
Enke Baldini, Silvia Cardarelli, Antonio Francesco Campese, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1121-1121
Open Access | Times Cited: 3
Monensin Inhibits Anaplastic Thyroid Cancer via Disrupting Mitochondrial Respiration and AMPK/mTOR Signaling
Yanli Li, Qianshu Sun, Sisi Chen, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 14, pp. 2539-2547
Closed Access | Times Cited: 9
Nutrition in Advanced Thyroid Cancer Patients
Laura Agate, Elisa Minaldi, Alessio Basolo, et al.
Nutrients (2022) Vol. 14, Iss. 6, pp. 1298-1298
Open Access | Times Cited: 9
Agrin is a novel oncogenic protein in thyroid cancer
Anna Adamiok‐Ostrowska, Małgorzata Grzanka, Barbara Czarnocka
Oncology Letters (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 5
Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms
C. Li, Xiaoxiao Dong, Q Q Yuan, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 8, pp. 1633-1650
Closed Access | Times Cited: 4
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments
Alessandro Prete, Erica Pieroni, Elena Marrama, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 5, pp. 1165-1173
Open Access | Times Cited: 4
Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives
Valentina Cirello, Carla Gambale, Alyaksandr V. Nikitski, et al.
Panminerva Medica (2024) Vol. 66, Iss. 2
Open Access | Times Cited: 1
Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer
Kazumasa Sekihara, Hidetomo Himuro, Soji Toda, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1286-1286
Open Access | Times Cited: 1
TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice
Noelle E. Gillis, Lauren Cozzens, Emily R Wilson, et al.
Endocrinology (2023) Vol. 164, Iss. 10
Open Access | Times Cited: 3
Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes
Siddharth Kunte, JONATHAN SHARETT, Wei Wei, et al.
Anticancer Research (2022) Vol. 42, Iss. 5, pp. 2531-2539
Open Access | Times Cited: 5
Poorly Differentiated Thyroid Carcinoma in a 19-Year-Old Young Female Patient: A Case Report
Atul Chavhan, Anjali A Vagga, Prachi Gedekar, et al.
Cureus (2024)
Open Access
Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers
Alessandro Prete, Carmelo Nucera
Current Opinion in Endocrine and Metabolic Research (2024) Vol. 37, pp. 100544-100544
Closed Access
A New Way Out of the Predicament of Anaplastic Thyroid Carcinoma From Existing Data Analysis
Yikun Zhou, Yang Zhao, Xi Ding, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 2
Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer
Leila Shobab, Leonard Wartofsky
Thyroid (2022) Vol. 33, Iss. 2, pp. 138-142
Closed Access | Times Cited: 2
TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice
Noelle E. Gillis, Lauren Cozzens, Emily R. Wilson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Response to PD-1 Blockers Alone or Combined with Anlotinib in Treatment of Anaplastic and Poorly Differentiated Thyroid Carcinoma : A Real-world Study to Identify Best-benefited Patients
Yifei Ma, Youlong Wang, Pengfei Zhu, et al.
Research Square (Research Square) (2022)
Open Access
Cancer anaplasique de la thyroïde
Réseau ENDOCAN-TUTHYREF
EMC - Endocrinologie - Nutrition (2022) Vol. 33, Iss. 4, pp. 1-7
Closed Access
Page 1

Scroll to top